• sample material: nasal swab or nasopharyngeal swab
• painless sample collection
• high-quality product
• rapid results in just 15 minutes
• bulk packaging of 20 pieces
• intended for professional use

Test specification

• SARS-CoV-2: specificity: 99,13%, sensitivity: 98,11%, accuracy: 99,13%
• Influenza A: specificity: 97,72%, sensitivity: 95,72%, accuracy: 92,95%
• Influenza B: specificity: 91,86%, sensitivity: 95,52%, accuracy: 95,93%
• RVS: specificity: 97,79%, sensitivity: 99,39%, accuracy: 98,93%
• Adenovirus: specificity: 97,79%, sensitivity: 97,39%, accuracy: 97,93%
• Mycoplasma pneumoniae: specificity: 99,98%, sensitivity: 96,19%, accuracy: 99,39%

The package contains

• 20 test cassettes
• 20 tubes with extraction buffer
• 40 single-use swabs
• user manual

Test application

• The test is intended for the qualitative assessment of infections caused by SARS-CoV-2, influenza A, influenza B, RSV, adenovirus, and Mycoplasma pneumoniae. This enables the detection or exclusion of the cause of the patient’s health issues. Accurate diagnosis allows for the implementation of the most effective therapy, reducing the time required for patient recovery.
• The test is particularly recommended for pediatricians, as children are exposed to such infections in school and preschool environments. Painless sample collection makes it suitable for the youngest patients.
• It is also intended for screening in primary care facilities and general practitioners’ offices, allowing for the rapid confirmation or exclusion of infection with one of the six most common respiratory pathogens.